Patients with FBN1 variants affecting a cysteine residue showed a higher rate of SV dilatation (p = 0.033) and tricuspid valve prolapse (p = 0.03) than patients with variants not involving a cysteine residue. The gene discussed is FBN1; the disease is tricuspid valve prolapse.